Medi-Clear invests in Nilpeter FB-17

 
The investment marks an important step in Medi-Clear's continued focus on efficiency, repeatability, and product development in a market where performance requirements and delivery expectations are rising.
 
Steve Watt, operations and technical director at Medi-Clear, said: 'As our offering continued to evolve and grow with new customers, products and applications, our existing equipment began to limit what we could do.'

'We needed to invest in new technology to bring capabilities and efficiencies into the business. Our focus areas were throughput and how we handled different materials, and we wanted a technology that would address those properly.'
 
Medi-Clear selected Nilpeter after following a close development process where the final press specification was shaped and refined as requirements evolved.
 
'We carefully defined what the right press specifications should look like for us through ideation and iterative testing,' Watt added. 'What made Nilpeter stand out was the commitment to the process, and the time, effort and responsiveness to our requirements, even as they changed. It felt less like a supplier relationship and more like a partnership, and that gave us real confidence that we were building the right bespoke relationship.'
 
Medi-Clear expects the Nilpeter FB-17 to unlock increased flexibility across its existing formats, while creating a stronger platform for new product development.
 
'This investment gives us opportunities that we simply didn't have before. It supports new product development options, and it also allows us to approach our existing portfolio in a leaner way, with improved efficiency and capability', said Watt.
 
John Hammond, Nilpeter UK, who led the engagement, underlines the importance of partnership and trust in projects where a customer's requirements are highly specific.
 
'From the beginning, this has been a genuinely collaborative process with Medi-Clear. Their requirements evolved as the specification took shape, and throughout we focused on transparency and getting the details right. The result is a bespoke FB-17 configuration built on partnership and trust, and a platform designed to support Medi-Clear's next steps in efficiency and innovation.'
 
Looking ahead, Medi-Clear sees the FB-17 as an important step in its ongoing focus on performance and capability.
 
'Our priority now is to see how the press performs in our operation and the value it delivers – we're confident it will play a meaningful role in supporting our goals,' Watt concludes.